Homebiotech

biotech

biotech

Experimental drug protects body from harmful effects of gluten

Jim Cornall - April 29, 2026

biotech

Japanese pharma companies shifting to earlier CDMO outsourcing

Jim Cornall - April 28, 2026

biotech

Promising cell model for dementia research

Jim Cornall - April 28, 2026

biotech

Antibodies offer hope for autoimmune diseases

Jim Cornall - April 28, 2026

biotech

myTomorrows and Rare Disease Research partner to improve access to rare disease clinical trials

Jim Cornall - April 22, 2026

biotech

Resolve Therapeutics and Institut Pasteur collaborate to identify cell-free RNA triggers in autoimmunity

Jim Cornall - April 22, 2026

biotech

Stem cell therapy for type 1 diabetes

Jim Cornall - April 21, 2026

biotech

New technique maps cancer drug uptake inside living cells

Jim Cornall - April 21, 2026

biotech

Group develops inhaled therapy to reduce lung damage from severe infections

Jim Cornall - April 21, 2026

biotech

Circio enters in vivo cell therapy evaluation agreement with Acuitas Therapeutics

Jim Cornall - April 20, 2026

biotech

CRISPR variant selectively targets tumour DNA

Jim Cornall - April 20, 2026

biotech

AI-powered biochip detects genetic markers in 20 minutes

Jim Cornall - April 20, 2026

123...72 Page 2 of 72

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Experimental drug protects body from harmful effects of gluten

Jim Cornall - April 29, 2026 0

An experimental drug may provide a new form of protection for people with coeliac disease. According to an international study led by the Universities...

Japanese pharma companies shifting to earlier CDMO outsourcing

biotech Jim Cornall - April 28, 2026 0

Promising cell model for dementia research

biotech Jim Cornall - April 28, 2026 0

Antibodies offer hope for autoimmune diseases

biotech Jim Cornall - April 28, 2026 0

New lung cancer model reveals tumour location shapes the immune response

biotech Jim Cornall - April 27, 2026 0